These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23070248)

  • 1. Hepatoid carcinoma of the lung with anaplastic lymphoma kinase gene rearrangement.
    Khozin S; Roth MJ; Rajan A; Smith K; Thomas A; Berman A; Giaccone G
    J Thorac Oncol; 2012 Nov; 7(11):e29-31. PubMed ID: 23070248
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic response to crizotinib in an ALK-positive adenocarcinoma patient with disseminated intravascular coagulation.
    Toyokawa G; Takenoyama M; Watanabe S; Toyozawa R; Inamasu E; Kojo M; Shiraishi Y; Morodomi Y; Takenaka T; Hirai F; Yamaguchi M; Taguchi K; Seto T; Ichinose Y
    J Thorac Oncol; 2013 Nov; 8(11):e96-8. PubMed ID: 24128725
    [No Abstract]   [Full Text] [Related]  

  • 3. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
    Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
    BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.
    Ko SJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Chung JH; Kim TJ; Lee KW; Kim K; Jheon S; Kim H; Lee JH; Lee CT
    BMC Cancer; 2014 May; 14():312. PubMed ID: 24885886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma.
    Chaft JE; Rekhtman N; Ladanyi M; Riely GJ
    J Thorac Oncol; 2012 Apr; 7(4):768-9. PubMed ID: 22425930
    [No Abstract]   [Full Text] [Related]  

  • 6. Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements.
    Park S; Park TS; Choi CM; Lee DH; Kim SW; Lee JS; Kim WS; Song JS; Lee JC
    Clin Lung Cancer; 2015 Sep; 16(5):e83-9. PubMed ID: 25682546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib.
    Hayashi N; Fujita A; Saikai T; Takabatake H; Sotoshiro M; Sekine K; Kawana A
    Intern Med; 2018 Mar; 57(5):713-716. PubMed ID: 29151522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas.
    Nishino M; Klepeis VE; Yeap BY; Bergethon K; Morales-Oyarvide V; Dias-Santagata D; Yagi Y; Mark EJ; Iafrate AJ; Mino-Kenudson M
    Mod Pathol; 2012 Nov; 25(11):1462-72. PubMed ID: 22743652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors.
    Levacq D; D'Haene N; de Wind R; Remmelink M; Berghmans T
    Lung Cancer; 2016 Dec; 102():38-41. PubMed ID: 27987586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.
    Ilie M; Long E; Butori C; Hofman V; Coelle C; Mauro V; Zahaf K; Marquette CH; Mouroux J; Paterlini-Bréchot P; Hofman P
    Ann Oncol; 2012 Nov; 23(11):2907-2913. PubMed ID: 22735679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Pleomorphic Carcinoma of the Lung Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement.
    Shiroyama T; Tanaka A; Tamiya M; Hamaguchi M; Osa A; Takeoka S; Tani E; Azuma Y; Morishita N; Suzuki H; Okamoto N; Kimura K; Kadota Y; Kawahara K; Hirashima T; Kawase I
    Intern Med; 2015; 54(21):2741-3. PubMed ID: 26521903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of ALK rearrangement-positive adenocarcinoma to small-cell lung cancer in association with acquired resistance to alectinib.
    Takegawa N; Hayashi H; Iizuka N; Takahama T; Ueda H; Tanaka K; Takeda M; Nakagawa K
    Ann Oncol; 2016 May; 27(5):953-5. PubMed ID: 26811347
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma.
    Caumont C; Veillon R; Gros A; Laharanne E; Bégueret H; Merlio JP
    Lung Cancer; 2016 Feb; 92():15-8. PubMed ID: 26775590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
    Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
    Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.
    Cha YJ; Kim HR; Shim HS
    J Transl Med; 2016 Oct; 14(1):296. PubMed ID: 27756333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation to sarcomatoid carcinoma in ALK-rearranged adenocarcinoma, which developed acquired resistance to crizotinib and received subsequent chemotherapies.
    Kobayashi Y; Sakao Y; Ito S; Park J; Kuroda H; Sakakura N; Usami N; Mitsudomi T; Yatabe Y
    J Thorac Oncol; 2013 Aug; 8(8):e75-8. PubMed ID: 23857406
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a novel ALK inhibitor-sensitive PRKCE-ALK gene fusion in lung adenocarcinoma.
    Wang L; Li L; Zhou X; Zhang D
    Lung Cancer; 2024 May; 191():107797. PubMed ID: 38669726
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of ALK rearrangement in an octogenarian patient with pleomorphic carcinoma of the lung.
    Maruyama R; Matsumura F; Shibata Y; Takahashi H; Okabayashi H; Kosai S; Honda I; Ohkawara S; Sugimoto M
    Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):167-9. PubMed ID: 24846683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
    Jeong CJ; Lee HY; Han J; Jeong JY; Lee KS; Choi YL; Choi JY
    Clin Nucl Med; 2015 Jan; 40(1):e34-9. PubMed ID: 25243942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.